Polymorphisms in SP1 binding sites within the COL1A1 gene are significantly associated with clinical phenotypes, including collagen disease and osteogenesis imperfecta (OI), with mutations at the rs1800012 site linked to bone mineral density in women aged 45 years and older [29]. Here, SP1 is linked to osteogenesis imperfecta.